Nalmefene – an Opioid Receptor Antagonist for the Treatment of Alcohol Dependence

A few days ago, the European Medicines Agency EMA has approved the opioid receptor antagonist nalmefene for the treatment of alcohol dependence. The substance will be marketed as Selincro® in Germany, manufacturer is the Danish company Lundbeck.

Nalmefene is not the first opioid receptor antagonist available for the treatment of alcohol dependence. Continue reading